The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals

Withdrawn before enrolling

Conditions studied: Hypertension, Pulmonary

In brief

The investigators aim to correlate noninvasive pulmonary artery systolic pressure (PASP) measurements obtained with and without echocardiographic contrast (Optison) during transthoracic echocardiography (TTE) with those obtained invasively and simultaneously during right heart catheterization, as the gold standard.

Key facts

Study ID

NCT02560116

Run by

Northwell Health

People needed

0

Starts

2015-06-01

Expected to finish

2015-12-01

Last updated by the study team

2016-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• consecutive patients (age ≥ 18 years old) undergoing right heart catheterization catheterization laboratory for various clinical indications as part of routine medical care;
• only patients with poor acoustic windows will be included (based on previous studies, body habitus);

You may not qualify if…

• atrial fibrillation or other irregular rhythms (bigeminy, frequent ectopy)
• pregnant women
• known allergy to perflutren, blood products, albumin
• patients who cannot receive blood products due to religious beliefs
• evidence of intracardiac right to left shunting

Where it is running

• North Shore - LIJ Health System — Manhasset, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.